Edward C. Giardino
ScholarGPS® ID: 37671300405636
Affiliation History
Discipline
Chemistry
Top Specialties
Medicinal Chemistry | Potassium Channel | Chemical Synthesis
Metrics Summary
Publication Count
27
Predicted Citations
792
Predicted h-index
17
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Patent Number: 8852556 (2014) |
High-content assays for evaluating cellular and hepatic diacylglycerol acyltransferase activity (journal article) Journal of Lipid Research, volume 51, issue 12, pages 3559-3567 (2010). |
Journal of Medicinal Chemistry, volume 53, issue 4, pages 1843-1856 (2010). |
Cooperative antithrombotic effect from the simultaneous inhibition of thrombin and factor Xa (journal article) Blood Coagulation & Fibrinolysis, volume 21, issue 2, pages 128-134 (2010). |
Torcetrapib Produces Endothelial Dysfunction Independent of Cholesteryl Ester Transfer Protein Inhibition (journal article) Journal of Cardiovascular Pharmacology, volume 55, issue 5, pages 459-468 (2010). |
Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif (journal article) Bioorganic & Medicinal Chemistry Letters, volume 18, issue 9, pages 2865-2870 (2008). |
7-Fluoroindazoles as Potent and Selective Inhibitors of Factor Xa (journal article) Journal of Medicinal Chemistry, volume 51, issue 2, pages 282-297 (2008). |
Journal of Medicinal Chemistry, volume 50, issue 23, pages 5868-5868 (2007). |
Exploration of Potential Prodrugs of RWJ‐445167, an Oxyguanidine‐based Dual Inhibitor of Thrombin and Factor Xa (journal article) Chemical Biology & Drug Design, volume 68, issue 1, pages 29-36 (2006). |
Journal of Biological Chemistry, volume 280, issue 18, pages 18001-18007 (2005). |
Journal of Medicinal Chemistry, volume 48, issue 6, pages 1984-2008 (2005). |
Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis (journal article) Bioorganic & Medicinal Chemistry Letters, volume 14, issue 14, pages 3727-3731 (2004). |
Antiplatelet and Antithrombotic Activity of RWJ-53308, A Novel Orally Active Glycoprotein IIb/IIIa Antagonist (journal article) Thrombosis Research, volume 104, issue 2, pages 113-126 (2001). |
Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. (journal article) The Journal of pharmacology and experimental therapeutics, volume 298, issue 1 (2001). |
Thrombosis Research, volume 98, issue 1, pages 83-93 (2000). |
Cardiovascular Profile of RWJ 29009, a New Potassium Channel Activator, in Anesthetized and Conscious Dogs (journal article) Journal of Cardiovascular Pharmacology, volume 2, issue 2, pages 300-310 (1994). |
Cardiovascular Profile of RWJ 29009, a New Potassium Channel Activator, in Anesthetized and Conscious Dogs (journal article) Journal of Cardiovascular Pharmacology, volume 23, issue 2, pages 300-310 (1994). |
Novel thieno[2,3-b]- and [3,4-b]pyrans as potassium channel openers. Thiophene systems—XVII (journal article) Bioorganic & Medicinal Chemistry, volume 1, issue 6, pages 423-435 (1993). |
Thiopene systems. 15. Synthesis and antihypertensive activity of 7- (subsituted benzamido)-6-hydroxythieno[3,2,-b]pyrans as nwe potassium channel activitors (journal article) Bioorganic & Medicinal Chemistry Letters, volume 3, issue 6, pages 1385-1388 (1993). |
RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent. (journal article) The Journal of pharmacology and experimental therapeutics, volume 267, issue 2 (1993). |